Stockreport

Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)

Osmotica Pharmaceuticals plc - Ordinary Shares  (OSMT) 
Last osmotica pharmaceuticals plc - ordinary shares earnings: 3/18 04:05 pm Check Earnings Report
PDF BRIDGEWATER, N.J., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Vertical Pharmaceuticals, LLC (a subsidiary of Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq [Read more]